NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 1 filers reported holding NEVRO CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $812,372 | -16.5% | 42,267 | +10.4% | 0.01% | -16.7% |
| Q2 2023 | $972,849 | -36.7% | 38,271 | -10.0% | 0.01% | -33.3% |
| Q1 2023 | $1,536,411 | -5.2% | 42,501 | +3.8% | 0.01% | 0.0% |
| Q4 2022 | $1,621,026 | -36.7% | 40,935 | -25.5% | 0.01% | -30.8% |
| Q3 2022 | $2,559,000 | +6.5% | 54,915 | +0.2% | 0.01% | +30.0% |
| Q2 2022 | $2,402,000 | -31.9% | 54,810 | +12.5% | 0.01% | -28.6% |
| Q1 2022 | $3,525,000 | +17.2% | 48,735 | +31.4% | 0.01% | -17.6% |
| Q4 2021 | $3,007,000 | -20.1% | 37,092 | +14.7% | 0.02% | -19.0% |
| Q3 2021 | $3,763,000 | -34.7% | 32,334 | -7.0% | 0.02% | -43.2% |
| Q2 2021 | $5,765,000 | – | 34,773 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |